Skip to main content
. Author manuscript; available in PMC: 2013 Feb 11.
Published in final edited form as: Free Radic Biol Med. 2007 May 18;43(8):1124–1131. doi: 10.1016/j.freeradbiomed.2007.05.019

Figure 2.

Figure 2

Effect of chromium niacinate and chromium picolinate supplementation on plasma IL-6 levels in STZ-treated diabetic rats. Values are Mean±SE. C, control; D, diabetic, D+CrN: Cr-N-treated D; D+Cr-P, Cr-P-treated diabetic rats. Rats were supplemented with control-buffer, Cr-N (400 µg Cr/kg BW) or Cr-P (400 µg Cr/Kg BW) by gavages daily for 7 wks. Differences between values marked * versus** (p<0.02), **versus# (p<0.02), **versus## (p<0.02) are significant.